GIP Protein, Mouse, Recombinant (His)
Product Specifications
Bioactivity
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals. GIP Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 8.7 kDa and the accession number is P48756.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKC82899-01 50 mg
N3- (3,4-Dihydro-2H-1-benzopyran-4-yl) -4H-1,2,4-triazole-3,5-diamine
Sign In for Pricing
View Details PKC82899-02 0.5 g
N3- (3,4-Dihydro-2H-1-benzopyran-4-yl) -4H-1,2,4-triazole-3,5-diamine
Sign In for Pricing
View Details 